Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin M Barker

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
JACC. Cardiovascular Interventions|October 23, 2010
Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivityColin M Barker, Sarah S Murray, Paul S Teirstein, et al.
The Annals of Thoracic Surgery|June 25, 2008
Outcome after surgery and percutaneous intervention for cardiogenic shock and left main diseaseMichael S Lee, Chi-Hong Tseng, Colin M Barker, et al.
JACC. Cardiovascular Interventions|March 4, 2019
Diagnostic Value of 3-Dimensional Vena Contracta Area for the Quantification of Residual Mitral Regurgitation After MitraClip ProcedureEleonora Avenatti, G Burkhard Mackensen, Kinan Carlos El-Tallawi, et al.
The Canadian Journal of Cardiology|December 17, 2023
Invasive Exercise Hemodynamics in Patients With Dynamic Secondary Mitral Regurgitation Before Transcatheter Edge-to-Edge RepairBassim El-Sabawi, Sandip K Zalawadiya, Colin M Barker, et al.
The Canadian Journal of Cardiology|August 10, 2023
Transcatheter Edge-to-Edge Repair in Patients With Hypertrophic Cardiomyopathy and Severe Mitral Regurgitation After Septal MyectomyBassim El-Sabawi, Ashish S Shah, D Marshall Brinkley, et al.
Journal of Comparative Effectiveness Research|July 6, 2021
Healthcare utilization and guideline-directed medical therapy in heart failure patients with reduced ejection fractionPeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Journal of Medical Economics|May 21, 2019
The healthcare burden of disease progression in medicare patients with functional mitral regurgitationPeter A McCullough, Hirsch S Mehta, David P Cork, et al.
Clinical Cardiology|August 3, 2021
Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fractionPeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 18, 2018
When to SAVR in the age of TAVR? A perspective on surgical aortic valve replacement in 2018Moritz C Wyler von Ballmoos, Colin M Barker, Ross M Reul, et al.
Journal of Comparative Effectiveness Research|November 11, 2020
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failureColin M Barker, David P Cork, Peter A McCullough, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
JACC. Cardiovascular Interventions|October 23, 2010
Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivityColin M Barker, Sarah S Murray, Paul S Teirstein, et al.
The Annals of Thoracic Surgery|June 25, 2008
Outcome after surgery and percutaneous intervention for cardiogenic shock and left main diseaseMichael S Lee, Chi-Hong Tseng, Colin M Barker, et al.
JACC. Cardiovascular Interventions|March 4, 2019
Diagnostic Value of 3-Dimensional Vena Contracta Area for the Quantification of Residual Mitral Regurgitation After MitraClip ProcedureEleonora Avenatti, G Burkhard Mackensen, Kinan Carlos El-Tallawi, et al.
The Canadian Journal of Cardiology|December 17, 2023
Invasive Exercise Hemodynamics in Patients With Dynamic Secondary Mitral Regurgitation Before Transcatheter Edge-to-Edge RepairBassim El-Sabawi, Sandip K Zalawadiya, Colin M Barker, et al.
The Canadian Journal of Cardiology|August 10, 2023
Transcatheter Edge-to-Edge Repair in Patients With Hypertrophic Cardiomyopathy and Severe Mitral Regurgitation After Septal MyectomyBassim El-Sabawi, Ashish S Shah, D Marshall Brinkley, et al.
Journal of Comparative Effectiveness Research|July 6, 2021
Healthcare utilization and guideline-directed medical therapy in heart failure patients with reduced ejection fractionPeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Journal of Medical Economics|May 21, 2019
The healthcare burden of disease progression in medicare patients with functional mitral regurgitationPeter A McCullough, Hirsch S Mehta, David P Cork, et al.
Clinical Cardiology|August 3, 2021
Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fractionPeter A McCullough, Hirsch S Mehta, Colin M Barker, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|April 18, 2018
When to SAVR in the age of TAVR? A perspective on surgical aortic valve replacement in 2018Moritz C Wyler von Ballmoos, Colin M Barker, Ross M Reul, et al.
Journal of Comparative Effectiveness Research|November 11, 2020
Healthcare utilization in clinically significant tricuspid regurgitation patients with and without heart failureColin M Barker, David P Cork, Peter A McCullough, et al.
Pageof 10